Marchex (NASDAQ:MCHX) and Nutex Health (NASDAQ:NUTX) Head-To-Head Analysis

Nutex Health (NASDAQ:NUTX) and Marchex (NASDAQ:MCHX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Insider and Institutional Ownership

5.3% of Nutex Health shares are held by institutional investors. Comparatively, 73.5% of Marchex shares are held by institutional investors. 38.5% of Nutex Health shares are held by insiders. Comparatively, 20.3% of Marchex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and price targets for Nutex Health and Marchex, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	0	1	0	3.00
Marchex	0	0	0	0	N/A

Nutex Health presently has a consensus target price of $150.00, suggesting a potential upside of 883.61%. Given Nutex Health’s higher possible upside, analysts plainly believe Nutex Health is more favorable than Marchex.

Profitability

This table compares Nutex Health and Marchex’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	-15.85%	-44.06%	-9.54%
Marchex	-13.97%	-15.17%	-11.52%

Risk & Volatility

Nutex Health has a beta of -0.07, meaning that its stock price is 107% less volatile than the S&P 500. Comparatively, Marchex has a beta of 1.99, meaning that its stock price is 99% more volatile than the S&P 500.

Earnings & Valuation

This table compares Nutex Health and Marchex’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$275.93 million	0.27	-$45.79 million	($10.59)	-1.44
Marchex	$48.82 million	1.83	-$9.91 million	($0.15)	-13.67

Marchex has lower revenue, but higher earnings than Nutex Health. Marchex is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Summary

Marchex beats Nutex Health on 7 of the 13 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About Marchex

Marchex, Inc., a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. Its products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, in order to identify actionable insights from conversations with their customers; Spotlight, an AI conversation analytics product for multi-location businesses; and Engage, a solution that provides locations with applications to enhance their overall performance. The company was incorporated in 2003 and is headquartered in Seattle, Washington.